Nauck M, Stockmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes
Early gastrointestinal symptoms appear in about 40% of users but remain mild
FDA status: It is not FDA-approved for cosmetic skin whitening in the US
Volkova A, Shadrina M, Kolomin T, et al (2016) Selank administration affects the expression of some genes involved in GABAergic neurotransmission
For example, the injections are not recommended for patients who are not clinically overweight with a BMI of 27 or more
The reason these new medications are such game changers is they really are effective, and its quite remarkable to help someone whos tried oftentimes for years, decades, maybe their entire adult life, to lose weight.